Morgan Stanley Says Buy While Blood Is In The Streets

Morgan Stanley sees recent growth fears as an opportunity to add exposure.

In a Cross-Asset Strategy research note dated October 14 reviewed by ValueWalk, the brokerage firm said that growth remains intact in the U.S. and they are recommending investments in U.S. high yield instruments, select emerging markets and the long-end of U.S. investment grade credit instruments.

Morgan Stanley paints a picture of the weakening world economy

Although some analysts think weaker oil, non-U.S. currencies, lower interest rates and the ECB rushing into quantitative easing are a sign of a weakening world economic picture, Morgan Stanley’s London analysts Andrew Sheets, Phanikiran Narparaju and Serena Tang think differently. Their...